https://m2.mtmt.hu/ hun 2026-07-28 00:13 JournalArticle 33688871 VALIDATED true 0 false 2026-05-22T19:32:54.303+0000 2025-10-27T07:37:52.190+0000 2023-03-08T13:29:46.961+0000 true 10067747 Reményiné Kállai Zsuzsa /api/admin/10067747 Admin Reményiné Kállai Zsuzsa (DE admin 4) true 2025-12-03T12:50:06.396+0000 2025-12-03T12:50:06.396+0000 2025-10-27T07:37:52.463+0000 true 10099440 Csernyik Rita /api/admin/10099440 Admin Csernyik Rita (MTMT központi admin) true Admin 10099440 /api/admin/10099440 Csernyik Rita (MTMT központi admin) Csernyik Rita true true 2025-10-21T01:37:28.906+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Diószegi, Ágnes true true /api/journal/10018879 REVIEWED BIOMOLECULES 2218-273X 2218-273X true false 10018879 false 10018879 true 2218-273X 2218-273X Journal FOREIGN 13 3 401 401 13 2023 Background: Impaired lipid metabolism contributes to accelerated inflammatory responses in addition to promoting the formation of atherosclerosis in systemic lupus erythematosus (SLE). We aimed to evaluate the lipid profile, inflammatory markers, and vascular diagnostic tests in active SLE patients to clarify the association between dyslipidemia and early vascular damage. Patients and Methods: 51 clinically active SLE patients and 41 age- and gender-matched control subjects were enrolled in the study. Lipoprotein subfractions were detected by Lipoprint. Brachial artery flow-mediated dilation and common carotid intima-media thickness were detected by ultrasonography. Arterial stiffness indicated by augmentation index (Aix) and pulse wave velocity was measured by arteriography. Results: We found significantly higher Aix, higher VLDL ratio, plasma triglyceride, ApoB100, and small HDL, as well as lower HDL-C, large HDL, and ApoA1 in patients with SLE. There was a significant positive correlation of Aix with triglyceride, VLDL, IDL-C, IDL-B, and LDL1. A backward stepwise multiple regression analysis showed IDL-C subfraction to be the best predictor of Aix. Conclusions: Our results indicate that in young patients with SLE, triglyceride-rich lipoproteins influence vascular function detected by Aix. These parameters may be assessed and integrated into the management plan for screening cardiovascular risk in patients with SLE. Funding 2025375 /api/funding/2025375 (K142273) false true Funding 2025376 /api/funding/2025376 (TKP2021-EGA-18) Támogató: NKFIH false true true 2023 true true true false true false GOLD 2026-05-22 true https://doi.org/10.3390/biom13030401 10 0 10 10 0 10 10 9 6 9 9 9 9 10 0 0 10 10 10 10 0 8 8 Folyóiratcikk Journal Article 24 10 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 2 2 2 2 2024 0 4 4 4 4 2025 0 4 4 4 4 Q1 false 10030122,10002882,10100639 false false false 2023-04-10T09:51:41.956+0000 Anyagcsere Betegségek Nem Önálló Tanszék (DE / ÁOK / BelgyI); Belgyógyászati Intézet (DE / ÁOK); Belgyógyászati és Hematológiai Klinika (SE / AOK / K); C épület (DE / KK / BelgyKL); ELKH-DE Vaszkuláris Patofiziológiai Kutatócsoport (DE / ÁOK); Klinikai Immunológiai Tanszék (DE / ÁOK / BelgyI) 7 31 6 8 0 true 10099440 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 106953391 /api/authorship/106953391 Diószegi, Ágnes [Diószegi, Ágnes (Belgyógyászat), szerző] Belgyógyászati Intézet (DE / ÁOK) 1 0.125 true false false Author 10057464 /api/author/10057464 Diószegi Ágnes (Belgyógyászat) Diószegi Ágnes true 10057464 true Diószegi Ágnes true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953392 /api/authorship/106953392 Lőrincz, Hajnalka [Lőrincz, Hajnalka (Egészségtudományok), szerző] Anyagcsere Betegségek Nem Önálló Tanszék (DE / ÁOK / BelgyI); Belgyógyászati Intézet (DE / ÁOK) 2 0.125 false false false Author 10037740 /api/author/10037740 Lőrincz Hajnalka (Egészségtudományok) Lőrincz Hajnalka true 10037740 true Lőrincz Hajnalka true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953393 /api/authorship/106953393 Kaáli, Eszter 3 0.125 false false false Kaáli Eszter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953394 /api/authorship/106953394 Soltész, Pál [Soltész, Pál (Klinikai orvostud...), szerző] C épület (DE / KK / BelgyKL); Belgyógyászati Intézet (DE / ÁOK) 4 0.125 false false false Author 10002882 /api/author/10002882 Soltész Pál (Klinikai orvostudomány) Soltész Pál true 10002882 true Soltész Pál true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953395 /api/authorship/106953395 Perge, Bianka [Perge, Bianka (belgyógyászat, im...), szerző] 5 0.125 false false false Author 10100639 /api/author/10100639 Perge Bianka (belgyógyászat, immunológia) Perge Bianka true true Perge Bianka true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953396 /api/authorship/106953396 Varga, Éva [Varga, Éva (belgyógyászat), szerző] Belgyógyászati és Hematológiai Klinika (SE / AOK / K) 6 0.125 false false false Author 10035380 /api/author/10035380 Varga Éva (belgyógyászat) Varga Éva true 10035380 true Varga Éva true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953397 /api/authorship/106953397 Harangi, Mariann [Harangi, Mariann (endokrinológia), szerző] Anyagcsere Betegségek Nem Önálló Tanszék (DE / ÁOK / BelgyI); Belgyógyászati Intézet (DE / ÁOK); ELKH-DE Vaszkuláris Patofiziológiai Kutatócsoport (DE / ÁOK) 7 0.125 false false false Author 10020547 /api/author/10020547 Harangi Mariann (endokrinológia) Harangi Mariann true 10020547 true Harangi Mariann true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106953398 /api/authorship/106953398 Tarr, Tünde ✉ [Tarr, Tünde (klinikai orvostud...), szerző] C épület (DE / KK / BelgyKL); Klinikai Immunológiai Tanszék (DE / ÁOK / BelgyI); Belgyógyászati Intézet (DE / ÁOK) 8 0.125 false true true Author 10030122 /api/author/10030122 Tarr Tünde (klinikai orvostudomány) Tarr Tünde true 10030122 true Tarr Tünde true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 23206800 /api/publicationidentifier/23206800 DOI: 10.3390/biom13030401 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.3390/biom13030401 https://doi.org/10.3390/biom13030401 false true PublicationIdentifier 23352126 /api/publicationidentifier/23352126 WoS: 000953989400001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000953989400001 https://www.webofscience.com/wos/woscc/full-record/000953989400001 true true PublicationIdentifier 23352123 /api/publicationidentifier/23352123 Scopus: 85151113623 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85151113623 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85151113623 false true PublicationIdentifier 23352124 /api/publicationidentifier/23352124 PubMed: 36979336 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 36979336 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36979336&dopt=Abstract false true SjrRating 11357702 /api/sjrrating/11357702 sjr:Q1 (2023) Scopus - Biochemistry BIOMOLECULES 2218-273X 2218-273X 88 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1303 /api/classificationexternal/1303 Scopus - Biochemistry true 1303 true Q1 DIRECT true true Reference 39173219 /api/reference/39173219 1. Bello, N., Meyers, K.J., Workman, J., Hartley, L., and McMahon, M. (Lupus, 2022). Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis, Lupus, online ahead of print., DOI: 10.1177/09612033221147471 1 10.1177/09612033221147471 false true Reference 39173220 /api/reference/39173220 2. Schoenfeld 2013: The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review., Semin. Arthritis Rheum., 43, p. 77, DOI: 10.1016/j.semarthrit.2012.12.002 2 10.1016/j.semarthrit.2012.12.002 false true Reference 39173221 /api/reference/39173221 3. Sinicato 2013: Risk factors in cardiovascular disease in systemic lupus erythematosus., Curr. Cardiol. Rev., 9, p. 15 3 false true Reference 39173222 /api/reference/39173222 4. Reiss 2021: Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention., Inflammation, 44, p. 1663, DOI: 10.1007/s10753-021-01455-6 4 10.1007/s10753-021-01455-6 false true Reference 39173223 /api/reference/39173223 5. Atta 2018: Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus., Clin. Rheumatol., 37, p. 1539, DOI: 10.1007/s10067-018-4051-0 5 10.1007/s10067-018-4051-0 false true Reference 39173224 /api/reference/39173224 6. Sun 2022: Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus., Front. Immunol., 13, p. 860586, DOI: 10.3389/fimmu.2022.860586 6 10.3389/fimmu.2022.860586 false true Reference 39173225 /api/reference/39173225 7. Yelnik 2022: Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients., Lupus, 31, p. 1379, DOI: 10.1177/09612033221114275 7 10.1177/09612033221114275 false true Reference 39173226 /api/reference/39173226 8. Borba 2006: Mechanisms of dyslipoproteinemias in systemic lupus erythematosus., Clin. Dev. Immunol., 13, p. 203, DOI: 10.1080/17402520600876945 8 10.1080/17402520600876945 false true Reference 39173227 /api/reference/39173227 9. Tarr 2016: High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus., Lipids Health Dis., 15, p. 60, DOI: 10.1186/s12944-016-0229-0 9 10.1186/s12944-016-0229-0 false true Reference 39173228 /api/reference/39173228 10. Szodoray 2017: Dyslipidemia in systemic lupus erythematosus., Immunol. Res., 65, p. 543, DOI: 10.1007/s12026-016-8892-9 10 10.1007/s12026-016-8892-9 false true Reference 39173229 /api/reference/39173229 11. Olusi 2011: Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus., Vasc. Health Risk Manag., 7, p. 75, DOI: 10.2147/VHRM.S17015 11 10.2147/VHRM.S17015 false true Reference 39173230 /api/reference/39173230 12. Goldberg 1996: Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis., J. Lipid. Res., 37, p. 693, DOI: 10.1016/S0022-2275(20)37569-6 12 10.1016/S0022-2275(20)37569-6 false true Reference 39173231 /api/reference/39173231 13. Borato 2016: Biomarkers in Obesity: Serum Myeloperoxidase and Traditional Cardiac Risk Parameters., Exp. Clin. Endocrinol. Diabetes, 124, p. 49, DOI: 10.1055/s-0035-1565093 13 10.1055/s-0035-1565093 false true Reference 39173232 /api/reference/39173232 14. 2022: Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus., Front. Immunol., 13, p. 827355, DOI: 10.3389/fimmu.2022.827355 14 10.3389/fimmu.2022.827355 false true Reference 39173233 /api/reference/39173233 15. Kerekes 2011: Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment., Autoimmun. Rev., 10, p. 416, DOI: 10.1016/j.autrev.2011.01.004 15 10.1016/j.autrev.2011.01.004 false true Reference 39173234 /api/reference/39173234 16. Cypiene 2009: Arterial wall dysfunction in systemic lupus erythematosus., Lupus, 18, p. 522, DOI: 10.1177/0961203308099625 16 10.1177/0961203308099625 false true Reference 39173235 /api/reference/39173235 17. Boros 2011: Early determinants of atherosclerosis in paediatric systemic lupus erythematosus., Clin. Exp. Rheumatol., 29, p. 575 17 false true Reference 39173236 /api/reference/39173236 18. Svenungsson 2008: Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus., Scand. J. Rheumatol., 37, p. 352, DOI: 10.1080/03009740802007514 18 10.1080/03009740802007514 false true Reference 39173237 /api/reference/39173237 19. Palmieri 2009: High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index., Nutr. Metab. Cardiovasc. Dis., 19, p. 234, DOI: 10.1016/j.numecd.2008.09.009 19 10.1016/j.numecd.2008.09.009 false true Reference 39173238 /api/reference/39173238 20. Kiss 2006: Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients., J. Autoimmun., 27, p. 211, DOI: 10.1016/j.jaut.2006.09.008 20 10.1016/j.jaut.2006.09.008 false true Reference 39173239 /api/reference/39173239 21. Cacciapaglia 2009: Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients., Lupus, 18, p. 249, DOI: 10.1177/0961203308097571 21 10.1177/0961203308097571 false true Reference 39173240 /api/reference/39173240 22. Fanlo-Maresma, M., Candás-Estébanez, B., Esteve-Luque, V., Padró-Miquel, A., Escrihuela-Vidal, F., Carratini-Moraes, M., Corbella, E., Corbella, X., and Pintó, X. (2021). Asymptomatic Carotid Atherosclerosis Cardiovascular Risk Factors and Common Hypertriglyceridemia Genetic Variants in Patients with Systemic Erythematosus Lupus. J. Clin. Med., 10., DOI: 10.3390/jcm10102218 22 10.3390/jcm10102218 false true Reference 39173241 /api/reference/39173241 23. Aringer 2019: 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus., Arthritis Rheumatol., 71, p. 1400, DOI: 10.1002/art.40930 23 10.1002/art.40930 false true Reference 39173242 /api/reference/39173242 24. Celermajer 1992: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis., Lancet, 340, p. 1111, DOI: 10.1016/0140-6736(92)93147-F 24 10.1016/0140-6736(92)93147-F false true Reference 39173243 /api/reference/39173243 25. Corretti 2002: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force., J. Am. Coll. Cardiol., 39, p. 257, DOI: 10.1016/S0735-1097(01)01746-6 25 10.1016/S0735-1097(01)01746-6 false true Reference 39173244 /api/reference/39173244 26. Szucs 2007: Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications., Rheumatology, 46, p. 759, DOI: 10.1093/rheumatology/kel426 26 10.1093/rheumatology/kel426 false true Reference 39173245 /api/reference/39173245 27. Baulmann 2008: A new oscillometric method for assessment of arterial stiffness: Comparison with tonometric and piezo-electronic methods., J. Hypertens., 26, p. 523, DOI: 10.1097/HJH.0b013e3282f314f7 27 10.1097/HJH.0b013e3282f314f7 false true Reference 39173246 /api/reference/39173246 28. Magometschnigg 2005: Blood pressure and arterial stiffness. A comparison of two devices for measuring augmentationindex and pulse wave velocity., Wien Med. Wochenschr., 155, p. 404, DOI: 10.1007/s10354-005-0209-x 28 10.1007/s10354-005-0209-x false true Reference 39173247 /api/reference/39173247 29. Lenkey 2010: Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity., J. Hypertens., 28, p. 2068, DOI: 10.1097/HJH.0b013e32833c8a1a 29 10.1097/HJH.0b013e32833c8a1a false true Reference 39173248 /api/reference/39173248 30. Salinas 2020: Remnant lipoproteins: Are they equal to or more atherogenic than LDL?., Curr. Opin. Lipidol., 31, p. 132, DOI: 10.1097/MOL.0000000000000682 30 10.1097/MOL.0000000000000682 false true Reference 39173249 /api/reference/39173249 31. Chapman 1988: Further resolution of the low density lipoprotein spectrum in normal human plasma: Physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation., J. Lipid Res., 29, p. 442, DOI: 10.1016/S0022-2275(20)38518-7 31 10.1016/S0022-2275(20)38518-7 false true Reference 39173250 /api/reference/39173250 32. Proctor 2004: Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy., Arter. Thromb. Vasc. Biol., 24, p. 2162, DOI: 10.1161/01.ATV.0000143859.75035.5a 32 10.1161/01.ATV.0000143859.75035.5a false true Reference 39173251 /api/reference/39173251 33. 2022: Triglyceride-Rich Lipoproteins: Their Role in Atherosclerosis., Rev. Invest. Clin., 74, p. 061 33 false true Reference 39173252 /api/reference/39173252 34. Nordestgaard 1992: IDL, VLDL, chylomicrons and atherosclerosis., Eur. J. Epidemiol., 8, p. 92, DOI: 10.1007/BF00145358 34 10.1007/BF00145358 false true Reference 39173253 /api/reference/39173253 35. Robinson, G.A., Peng, J., Pineda-Torra, I., Ciurtin, C., and Jury, E.C. (2021). Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk. Metabolites, 12., DOI: 10.3390/metabo12010003 35 10.3390/metabo12010003 false true Reference 39173254 /api/reference/39173254 36. Svensson 2021: Impaired Microcirculation and Vascular Hemodynamics in Relation to Macrocirculation in Patients With Systemic Lupus Erythematosus., Front. Med., 8, p. 722758, DOI: 10.3389/fmed.2021.722758 36 10.3389/fmed.2021.722758 false true Reference 39173255 /api/reference/39173255 37. Cervera 2020: Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis., Atherosclerosis, 297, p. 55, DOI: 10.1016/j.atherosclerosis.2020.01.028 37 10.1016/j.atherosclerosis.2020.01.028 false true Reference 39173256 /api/reference/39173256 38. Chan 2020: Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus., Arthritis Rheumatol., 72, p. 972, DOI: 10.1002/art.41213 38 10.1002/art.41213 false true Reference 39173257 /api/reference/39173257 39. Tselios 2016: Dyslipidemia in systemic lupus erythematosus: Just another comorbidity?., Semin. Arthritis Rheum., 45, p. 604, DOI: 10.1016/j.semarthrit.2015.10.010 39 10.1016/j.semarthrit.2015.10.010 false true Reference 39173258 /api/reference/39173258 40. Graziadei 2003: Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis., Lupus, 12, p. 409, DOI: 10.1191/0961203303lu313cr 40 10.1191/0961203303lu313cr false true Reference 39173259 /api/reference/39173259 41. Wadström, B.N., Pedersen, K.M., Wulff, A.B., and Nordestgaard, B.G. (2023). Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur. Heart J., ehac822., DOI: 10.1093/eurheartj/ehac822 41 10.1093/eurheartj/ehac822 false true /api/publication/33688871 Diószegi Ágnes et al. Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus. (2023) BIOMOLECULES 2218-273X 2218-273X 13 3<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10057464"><a href="/gui2/?type=authors&mode=browse&sel=10057464" target="_blank">Diószegi Ágnes (<span class="authorship-author-name">Diószegi Ágnes</span> <span class="authorAux-mtmt"> Belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Belgyógyászati Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10037740"><a href="/gui2/?type=authors&mode=browse&sel=10037740" target="_blank">Lőrincz Hajnalka (<span class="authorship-author-name">Lőrincz Hajnalka</span> <span class="authorAux-mtmt"> Egészségtudományok</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/<span title="Belgyógyászati Intézet">BelgyI</span>/Anyagcsere Betegségek Nem Önálló Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Belgyógyászati Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kaáli Eszter </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10002882"><a href="/gui2/?type=authors&mode=browse&sel=10002882" target="_blank">Soltész Pál (<span class="authorship-author-name">Soltész Pál</span> <span class="authorAux-mtmt"> Klinikai orvostudomány</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Klinikai Központ">KK</span>/<span title="Belgyógyászati Klinika">BelgyKL</span>/C épület; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Belgyógyászati Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10100639"><a href="/gui2/?type=authors&mode=browse&sel=10100639" target="_blank">Perge Bianka (<span class="authorship-author-name">Perge Bianka</span> <span class="authorAux-mtmt"> belgyógyászat, immunológia</span>) </a> </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10035380"><a href="/gui2/?type=authors&mode=browse&sel=10035380" target="_blank">Varga Éva (<span class="authorship-author-name">Varga Éva</span> <span class="authorAux-mtmt"> belgyógyászat</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Hematológiai Klinika</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10020547"><a href="/gui2/?type=authors&mode=browse&sel=10020547" target="_blank">Harangi Mariann (<span class="authorship-author-name">Harangi Mariann</span> <span class="authorAux-mtmt"> endokrinológia</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/<span title="Belgyógyászati Intézet">BelgyI</span>/Anyagcsere Betegségek Nem Önálló Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Belgyógyászati Intézet; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/ELKH-DE Vaszkuláris Patofiziológiai Kutatócsoport </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10030122"><a href="/gui2/?type=authors&mode=browse&sel=10030122" target="_blank">Tarr Tünde ✉ (<span class="authorship-author-name">Tarr Tünde</span> <span class="authorAux-mtmt"> klinikai orvostudomány</span>) </a> </span> <span class="author-affil"><span title="Debreceni Egyetem">DE</span>/<span title="Klinikai Központ">KK</span>/<span title="Belgyógyászati Klinika">BelgyKL</span>/C épület; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/<span title="Belgyógyászati Intézet">BelgyI</span>/Klinikai Immunológiai Tanszék; <span title="Debreceni Egyetem">DE</span>/<span title="Általános Orvostudományi Kar">ÁOK</span>/Belgyógyászati Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;33688871" target="_blank">Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus</a></div> <div> <span class="journal-title">BIOMOLECULES</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/2218-273X">2218-273X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/2218-273X">2218-273X</a>)</span>: <span class="journal-volume">13</span> <span class="journal-issue">3</span> <span class="page"> Paper 401. 13 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.3390/biom13030401" target="_blank" href="https://doi.org/10.3390/biom13030401"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000953989400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000953989400001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85151113623" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85151113623"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="36979336" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36979336&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Biochemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 10</span> | Független: 10 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 9 | Scopus jelölt:&nbsp;6 | WoS/Scopus jelölt:&nbsp;9 | DOI jelölt:&nbsp;10 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;33688871&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 8 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 33688871</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (K142273), (TKP2021-EGA-18) Támogató: NKFIH </div> <div class="lastModified">Utolsó módosítás: 2025.10.27. 08:37 Csernyik Rita (MTMT központi admin) </div> <div class="lockedBy">Központi kezelésű 2025.10.21. 03:37 Csernyik Rita (MTMT központi admin) </div> </div></div>